Stay updated on LY2880070 in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.

Latest updates to the LY2880070 in Advanced Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check12 days agoChange DetectedDifference0.6%
- Check20 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025, and the revision number has been updated from v2.16.2 to v2.16.4.SummaryDifference2%
- Check27 days agoChange DetectedThe page has removed a reference to a phase 1b study involving the oral chk1 inhibitor LY2880070 and its combination with gemcitabine, which was presented at the 2020 ASCO Annual Meeting.SummaryDifference2%
- Check34 days agoChange DetectedThe web page has been updated to reflect the latest version, v2.16.2, and includes new information about a phase 1b study of an oral chk1 inhibitor in combination with gemcitabine for cancer patients.SummaryDifference1%
- Check41 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, previous content related to a specific clinical study and an older revision number has been removed.SummaryDifference3%
Stay in the know with updates to LY2880070 in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.